Skip to content

Resource Library

Search Result

February 25, 2019 | Infographic

How long acting injectables can help improve medication adherence.

Category: Organized, evidence-based care
Key Audience: All clinicians
Tags: LAIs, LAMs, Long Acting Injectable Medications, Long-Acting Injectables, Long-Acting Medications
February 25, 2019 | Clinical Guidelines

A detailed guide of how clozapine works for treatment. Part 2 of 4.

Category: Organized, evidence-based care
Key Audience: All clinicians
Tags: LAIs, LAMs, Long Acting Injectable Medications, Long-Acting Injectables, Long-Acting Medications
February 25, 2019 | Fact Sheet

These questions about the patient's history and details on antipsychotic class and depot delivery technology will help in making decisions on the appropriate agent to use.

Category: Organized, evidence-based care
Key Audience: All clinicians
Tags: LAIs, LAMs, Long Acting Injectable Medications, Long-Acting Injectables, Long-Acting Medications
February 25, 2019 | Fact Sheet

Use the REAP MODEL to guide patients to considering clozapine when there has been a persistence of specific schizophrenia symptoms despite treatment with other antipsychotics. REAP is a shared model for you and your patients to make decisions together, within the evidence base.

Category: Organized, evidence-based care
Key Audience: All clinicians
Tags: LAIs, LAMs, Long Acting Injectable Medications, Long-Acting Injectables, Long-Acting Medications
February 25, 2019 | Fact Sheet

This case study follows David, now in his early 20s, who entered treatment at a first episode outpatient clinic following a first inpatient psychiatric admission.

Category: Organized, evidence-based care
Key Audience: All clinicians
Tags: LAIs, LAMs, Long Acting Injectable Medications, Long-Acting Injectables, Long-Acting Medications
February 25, 2019 | Faq

Frequently asked questions covering whether to use clozapine, dosage suggestions, the most common side effects and more.

Category: Organized, evidence-based care
Tags: LAIs, LAMs, Long Acting Injectable Medications, Long-Acting Injectables, Long-Acting Medications
November 26, 2018 | Fact Sheet

Long-acting injectable antipsychotic medications (LAIs) are a valuable approach to enhancing medication adherence in patients with schizophrenia. This desk guide is designed to help providers obtain LAI coverage for their patients.

Category: Organized, evidence-based care
Key Audience: All clinicians
Tags: LAIs, LAMs, Long Acting Injectable Medications, Long-Acting Injectables, Long-Acting Medications
August 23, 2018 | Webinars

Northwell Health worked alongside research and design company Clinvue to conduct an ethnographic study that interviewed patients, clinicians, providers and payers to understand their perceptions and barriers to use of LAIs. Recording: https://register.gotowebinar.com/recording/4938775727499305730

Category: Medication Management
Key Audience: All clinicians
Tags: LAIs, LAMs, Long Acting Injectable Medications, Long-Acting Injectables, Long-Acting Medications
April 26, 2018 | Webinars

Learn how to access and navigate the clozapine and long-acting injectable antipsychotics (LAIs) toolkits through the Center for Practice Innovations learning management system. View recording: https://register.gotowebinar.com/recording/5088996501014479874

Category: Medication Management
Key Audience: All clinicians
Tags: LAIs, LAMs, Long Acting Injectable Medications, Long-Acting Injectables, Long-Acting Medications
January 30, 2017 | Webinars

Join Dr. John Kane and his colleagues from Northwell Health in exploring how to use data to identify optimal candidates for the use of long acting injectable medication and clozapine. https://attendee.gotowebinar.com/recording/2780147417030205185

Category: Data Jams
Key Audience: All clinicians
Tags: Clozapine, Long Acting Injectable Medications
The Care Transitions Network is made possible by a grant made to the National Council for Behavioral Health by the Centers for Medicare and Medicaid Services, in a partnership between the National Council, Montefiore Medical Center, Northwell Health (formerly North Shore-LIJ Health System), the New York State Office of Mental Health and Netsmart Technologies. Contact us by emailing CareTransitions@TheNationalCouncil.org or calling 202-849-4920. The project described was supported by Funding Opportunity Number CMS-1L1-15-003 from the U.S. Department of Health & Human Services, Centers for Medicare & Medicaid Services. Disclaimer: The contents provided are solely the responsibility of the authors and do not necessarily represent the official views of HHS or any of its agencies.
©2019 National Council for Behavioral Health. All Rights Reserved.
The National Council for Behavioral Health is a 501(c)(3) nonprofit association (EIN 23-7092671).